Tuesday, June 15, 2021
The New York Times recently ran an article examining polypharmacy problems in elders, Looking to Tackle Prescription Overload. "[P]olypharmacy refers to an increasing overload of drugs that may not benefit the patient or interact well with one another, and that may cause harm including falls, cognitive impairment, hospitalization and death. It has sparked interest in “deprescribing”: the practice in which doctors and patients regularly review medication regimens to prune away risky or unnecessary drugs."
One solution, the focus of this article, is deprescribing. For example, "the Drive to Deprescribe campaign, [was] launched last month by the Society for Post-Acute and Long-Term Care Medicine, known as AMDA, which represents medical directors and administrators of long-term care facilities, where polypharmacy is particularly prevalent."